DARE vs IT · rev $1.0M vs P/E 16, rev $6.27B
Dare Bioscience Inc (DARE) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Dare Bioscience Inc (DARE) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported DARE revenue for 2025-12-31 was $1.0M. Net income was -$13.4M. Revenue was up 10429.4% from 2024-12-31 to 2025-12-31. DARE currently screens at market cap $21.2M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
DARE currently screens at market cap $21.2M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the DARE and IT stock pages for the full models.
Not investment advice.